Phase 1 of the randomized clinical trials regarding the edible rice vaccine against cholera had been a success. Further trials are expected for the cholera vaccines to be produced to combat the deadly cholera bacteria.
Almost 90 percent of the cancer patients had tested positive with the coronavirus antibodies after they were given shots of Pfizer-BioNTech's vaccine. In just a span of two weeks, those who obtained the second dose are proven to receive the vaccine well.
A recent study by the CDC confirms that fully vaccinated people are not required to wear a mask. This lifts the mask mandate and further proves the effectiveness of vaccines, specifically from Pfizer and Moderna.